Jubilant Life to hike Niacin prices by 18%

Company's nutrition business is backward integrated up to the initial raw material stage with global scale of operations

Press Trust of India Mumbai
Last Updated : Mar 13 2014 | 6:07 PM IST
Drug-maker Jubilant Life Sciences today announced a price increase of 18% for Niacin feed-grade, with immediate effect.

Jubilant Life Sciences, ranked among the largest makers of vitamin B3 (Niacin & Niacinamide) in the world, announced a price increase of 18% for Niacin feed-grade, with immediate effect, for non-contract customers and wherever existing contracts permit, a company statement said.

The company's nutrition business is backward integrated up to the initial raw material stage with global scale of operations.

Also Read

Jubilant Life Sciences is engaged in manufacture and supply of Active Pharmaceutical Ingredients (APIs), solid dosage formulations, radio pharmaceuticals, allergy therapy products and life science ingredients.

It also provides services in contract manufacturing of sterile injectables and ointments, creams and liquids and drug discovery and development.

The company has 10 manufacturing facilities in India, the US and Canada and a team of over 6,300 people across the globe.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 13 2014 | 6:06 PM IST

Next Story